Drugs / Varicella vaccine
Varicella vaccine
also known as
AVAXIM 80U · OKAVAX · Avaxim · AVAXIM 80U Pediatric vaccine · varicella live attenuated vaccine · VARIVAX
Trials 15 · a red edge is where a trial was stopped
Also used as a comparator or background therapy in 7 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/22 trials | ||||||
| Phase 1/2 | NCT04072497 Comparator | Nov 2018 → Apr 2020 | herpes zoster | Shanghai Institute Of Biological Products | Completed | No outcome recorded |
| Phase 1/2 | NCT00322049 Comparator | Feb 2004 → Jun 2009 | dengue disease | U.S. Army Medical Research and Development Command | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01064141 Comparator | Jan 2010 → Sep 2012 | Dengue hemorrhagic fever | Sanofi | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT01190228 Comparator | Aug → Oct 2010 | Japanese encephalitis, chickenpox | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT02026089 Comparator | Dec 2021 → Jun 2022 | chickenpox | University of Colorado, Denver | Withdrawn | No outcome recorded |
| Phase 4 | NCT01693380 Background | May → Jun 2009 | influenza | Butantan Institute | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT06313762 Background | Jan 2022 → Jan 2024 | — | Jordi Gol Institute for Primary Care Research | Completed | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 23 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Varicella vaccine | “of Meningococcal C conjugate vaccine, and one dose (0.5ml), one month later, of varicella vaccine, IM administered.” NCT01693380 ↗19“Subjects will be coadministered with inactivated SARS-CoV-2 vaccine and varicella vaccine.” NCT05952505 ↗ “Give 2 doses varicella vaccine (a single 0.5 mL) and get blood samples at 0,1.5,4.5 month” NCT01866566 ↗ “1 dose Varicella vaccine and 1 dose MMR given at the same time” NCT02146469 ↗ “Give the second varicella vaccine (a single 0.5 ml)” NCT02173899 ↗ “Varicella Vaccine” NCT06891872 ↗ |
| Known as | Avaxim | “Healthy anti-hepatitis A virus seronegative subjects aged 13 to 19 yr were randomized in three equal groups to receive two doses of Avaxim™, Epaxal®, or Havrix®, 6 to 12 months apart.” PMID 26770041 ↗ Dec 2015 |
| Known as | AVAXIM 80U | “AVAXIM® 80U” NCT01064141 ↗ |
| Known as | AVAXIM 80U Pediatric vaccine | “AVAXIM 80U Pediatric vaccine” NCT00483470 ↗ |
| Known as | OKAVAX | “OKAVAX®” NCT01064141 ↗ |
| Known as | varicella live attenuated vaccine | “The goal of this clinical trial is to evaluate the immunogenicity of simultaneous administration of varicella live attenuated vaccine (varicella vaccine hereafter) and...” NCT06987942 ↗ |
| Known as | VARIVAX | “varicella vaccine (VARIVAX)” NCT00213304 ↗ |
| Modality | Vaccine | “Safety and Immunogenicity of Live Attenuated Oka/Merck Varicella Vaccine in Children Listed to Undergo Solid Organ Transplantation” NCT00213304 ↗ |
| Route | Subcutaneous | “0.5 mL (single dose), Subcutaneous” NCT01190228 ↗ |